Silicon Wafer is often used as a substrate material for semiconductor electronic devices. It is a key component and high-cost upstream raw material for manufacturing chips in the semiconductor industry. Indeed, it is a vital component for all electronic products, such as computers, communications products, automobiles, consumer electronics, etc.

Recently, the Science and Technology Department of Jiangsu Province announced the results of the 2021 Jiangsu Science and Technology Award. MayAir Technology (China) Co., Ltd. (hereinafter referred to as "MayAir"), being the unit to complete with a second achievement for "Key Technology and Application of High Efficiency and Low Resistance Bacteria of Glass Microfiber Air Filter Material", had won the third prize.

In recent years, with the outbreak of the COVID-19 epidemic, the demand for antibody drugs in the pharmaceutical field has increased. Benefiting from the reform of the drug review and approval system, the barriers to production capacity, output, technology, etc. of various pharmaceutical companies have continued to be considerably reduced. Our country's antibody-drug industry has also achieved rapid growth. Among them, monoclonal antibody drugs play a pivotal role in treating tumours, autoimmunity, metabolism, viral infection, and other diseases because of their high ability to target effectively and precisely. MayAir provided a full range of environmental process protection to construct the local A-level environmental monoclonal antibody drug production project for BeiGene (Guangzhou).

The project is for a semiconductor design and manufacturing enterprise in Zhejiang, which is headquartered in Hangzhou. The company focuses on the design and manufacture of memory chips and related chips, and provides semiconductor chips and application solutions for the Internet of Things, smart transmission terminals, industrial control and automotive electronics.

Recently, the mutated strain of Omicron has been spreading widely around the world. Thus, the global new covid-19 pneumonia pandemic situation has once again entered into an intense stage. In response to the urgent need for clinical gene amplification nucleic acid testing of the new coronavirus, and to satisfy the prerequisite for biosafety requirements in clinical testing, the need for pandemic prevention and control, with efficiency and rapid deployment features, have been combined to satisfy the supply needs of biosafety laboratories for the prevention and control of the new covid-19 pandemic and for future public health events. China rapidly established shelter-type and mobile nucleic acid testing laboratories have played an important role in improving nucleic acid testing capabilities, expanding testing coverage, and assisting the public in pandemic prevention and control.

The 61st China National Pharmaceutical Machinery Exposition (Autumn 2021) was officially launched at the Chengdu Western International Expo City, China, on Nov. 2, 2021. This event fulfilled the industry’s expectations and gained national attention, where it focused on pharmaceutical equipment and integrated the industry’s high-quality resources.

The grand opening of the 22nd National Hospital Construction, Equipment and Management Exhibition (the Hospital Construction Exhibition) was held successfully at the Shenzhen International Convention and Exhibition Centre. MayAir showcased a variety of medical-grade purification products that successfully combined purification technology with hospital construction.